Hormone News and Research

RSS

A hormone is a chemical released by one or more cells that affects cells in other parts of the organism. Only a small amount of hormone is required to alter cell metabolism. It is essentially a chemical messenger that transports a signal from one cell to another.

OPKO Health acquires Cytochroma

OPKO Health, Inc. announced that it has completed the acquisition of Cytochroma Inc. Cytochroma's lead products include CTAP101 Capsules, a vitamin D prohormone to treat secondary hyperparathyroidism (SHPT) in patients with stage 3 or 4 chronic kidney disease (CKD) and vitamin D insufficiency, and Fermagate Tablets, a new and potent non-absorbed phosphate binder to treat hyperphosphatemia in CKD patients on chronic hemodialysis.

4 Mar 2013

Scientists discover enzyme regulation that catalyzes chain elongation in the terpenoid pathway

Max Planck scientists in Jena, Germany, have discovered an unusual regulation of enzymes that catalyze chain elongation in an important secondary metabolism, the terpenoid pathway.

2 Mar 2013

Chicago's poorest neighborhoods to experience demand for additional primary care doctors

Some of Chicago's poorest neighborhoods are expected to see the greatest demand for additional primary care doctors in 2014, as the Affordable Care Act boosts the number of newly insured patients seeking medical services, a new study has found.

2 Mar 2013

Tooth loss due to periodontal disease is more prevalent among postmenopausal women

Postmenopausal women who have smoked are at much higher risk of losing their teeth than women who never smoked, according to a new study published and featured on the cover of the Journal of the American Dental Association by researchers at the University at Buffalo.

2 Mar 2013

Synthetic progesterone birth control injections have vulnerability to certain infections: Research

Women who are pregnant or using synthetic progesterone birth control injections have a conspicuous vulnerability to certain infections including malaria, Listeria, HIV, and herpes simplex virus.

2 Mar 2013

Thyroid hormone may help reduce heart damage in humans with cardiac diseases

Thyroid hormone treatment administered to rats at the time of a heart attack (myocardial infarction) led to significant reduction in the loss of heart muscle cells and improvement in heart function, according to a study published by a team of researchers led by A. Martin Gerdes and Yue-Feng Chen from New York Institute of Technology College of Osteopathic Medicine.

1 Mar 2013

Physical activity has no relation with risk of non-invasive breast cancer

A European study published in the 'Cancer Epidemiology, Biomarkers & Prevention' journal has analysed the association between physical activities and in situ or non-invasive breast cancer, or, in other words, cancer that has not yet invaded cells within or outside of the breast.

1 Mar 2013

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

The March 2013 issue of The Journal of Urology, the official journal of The American Urological Association, includes a study conducted by four physicians from Radiotherapy Clinics of Georgia (RCOG), a Vantage Oncology affiliate.

28 Feb 2013

Study indicates how gastric bypass reverses diabetes

In a substudy of the STAMPEDE trial (Surgical Therapy And Medications Potentially Eradicate Diabetes Efficiently), Cleveland Clinic researchers have found that gastric bypass surgery reverses diabetes by uniquely restoring pancreatic function in moderately obese patients with uncontrolled type 2 diabetes.

28 Feb 2013

Long-term treatment with spironolactone improves left ventricular diastolic function in HF patients

Among patients with heart failure with preserved ejection fraction, long-term treatment with the medication spironolactone improved left ventricular diastolic function but did not affect maximal exercise capacity, patient symptoms, or quality of life, according to a study appearing in the February 27 issue of JAMA.

28 Feb 2013

Newborn screening improves detection of lethal form of congenital adrenal hyperplasia (CAH) in girls as well as boys

Contrary to current belief, routine newborn screening improves the detection of the lethal form of congenital adrenal hyperplasia (CAH) in girls as well as boys, saving lives in both sexes, according to a unique study of CAH during the last 100 years published Online First in The Lancet Diabetes and Endocrinology.

27 Feb 2013

FDA accepts Antares Pharma's New Drug Application for OTREXUP

Antares Pharma, Inc. today announced that the New Drug Application for OTREXUP, a potential new product for the subcutaneous delivery of methotrexate using Medi-Jet technology, has been accepted by the U.S. Food and Drug Administration indicating that the application is sufficiently complete to permit a substantive review.

27 Feb 2013

Hormone News and Research

Further Reading

OPKO Health acquires Cytochroma

Scientists discover enzyme regulation that catalyzes chain elongation in the terpenoid pathway

Chicago's poorest neighborhoods to experience demand for additional primary care doctors

Tooth loss due to periodontal disease is more prevalent among postmenopausal women

Synthetic progesterone birth control injections have vulnerability to certain infections: Research

Thyroid hormone may help reduce heart damage in humans with cardiac diseases

Physical activity has no relation with risk of non-invasive breast cancer

First study ever to analyze 25 years of data after radiation therapy for prostate cancer patients

Study indicates how gastric bypass reverses diabetes

Long-term treatment with spironolactone improves left ventricular diastolic function in HF patients

Newborn screening improves detection of lethal form of congenital adrenal hyperplasia (CAH) in girls as well as boys

FDA accepts Antares Pharma's New Drug Application for OTREXUP

Researchers to discuss health issues at Society of Toxicology's Annual Meeting and ToxExpo

Follow up evaluations necessary for 15 years after radiation therapy for prostate cancer patients

Shionogi receives FDA approval for Osphena to treat women with severe dyspareunia

Study finds major risk factor behind increased risk of adverse outcomes in IVF pregnancies

Recombinant Newcastle disease virus kills all kinds of prostate cancer cells

Glide Pharma announces completion of $21.4 million investment round

Henry Ford Hospital scientists to research into hypertension and tissue and organ damage

GLP-1 may increase risk of hospitalization for people with acute pancreatitis

Viva Saliva Book: The ultimate guide to saliva Book preview Download eBook

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News